New progress in basic research, clinical diagnosis and treatment of pancreatic cancer in 2022
Pancreatic cancer is the sixth leading cause of cancer-related death in China. It is characterized by high malignancy and concealment at early stages. More than 80% of patients have progressed to advanced stages at the time of diagnosis, and missed the opportunity of surgical resection. Pancreatic c...
Main Author: | WANG Xu, CHENG He, LIU Chen, YU Xianjun |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of China Oncology
2023-01-01
|
Series: | Zhongguo aizheng zazhi |
Subjects: | |
Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1676258252345-718689756.pdf |
Similar Items
-
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
by: TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun
Published: (2021-01-01) -
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2023
by: LI Tianjiao, YE Longyun, JIN Kaizhou, WU Weiding, YU Xianjun
Published: (2024-01-01) -
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2021
by: ZHU Xinzhe, LI Hao, XU Huaxiang, LUO Guopei, YU Xianjun
Published: (2022-01-01) -
Advances in basic research, clinical diagnosis and treatment of prostate cancer in 2022
by: PAN Jian, ZHU Yao, DAI Bo, YE Dingwei
Published: (2023-03-01) -
Advances in basic research, clinical diagnosis and treatment of bladder cancer in 2022
by: ZHENG Shengfeng, ZHU Yiping, YE Dingwei
Published: (2023-03-01)